Copyright Reports & Markets. All rights reserved.

Global Autologous Cell Therapy Market Research Report 2012-2024

Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 Bone Marrow
        • 1.2.1.2 Epidermis
      • 1.2.2 by Application
        • 1.2.2.1 Neurology
        • 1.2.2.2 Orthopedics
        • 1.2.2.3 Cancer
        • 1.2.2.4 Wound Healing
        • 1.2.2.5 CVD
        • 1.2.2.6 Autoimmune
        • 1.2.2.7 Others
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 Bone Marrow Market, 2013-2018
      • 4.1.2 Epidermis Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 Bone Marrow Market Forecast, 2019-2024
      • 4.2.2 Epidermis Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 Neurology Market, 2013-2018
      • 5.1.2 Orthopedics Market, 2013-2018
      • 5.1.3 Cancer Market, 2013-2018
      • 5.1.4 Wound Healing Market, 2013-2018
      • 5.1.5 CVD Market, 2013-2018
      • 5.1.6 Autoimmune Market, 2013-2018
      • 5.1.7 Others Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 Neurology Market Forecast, 2019-2024
      • 5.2.2 Orthopedics Market Forecast, 2019-2024
      • 5.2.3 Cancer Market Forecast, 2019-2024
      • 5.2.4 Wound Healing Market Forecast, 2019-2024
      • 5.2.5 CVD Market Forecast, 2019-2024
      • 5.2.6 Autoimmune Market Forecast, 2019-2024
      • 5.2.7 Others Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 BioTime, Inc.
    • 8.2 BrainStorm Cell Therapeutics
    • 8.3 Caladrius Biosciences, Inc.
    • 8.4 Fibrocell Science, Inc.
    • 8.5 Opexa Therapeutics, Inc.
    • 8.6 Pharmicell Co., Inc.
    • 8.7 Regeneus Ltd.
    • 8.8 TiGenix NV
    • 8.9 TxCell SA
    • 8.10 U.S. Stem Cell, Inc.
    • 8.11 Vericel Corporation

    9 Conclusion

    Summary
    The global Autologous Cell Therapy market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    Bone Marrow 
    Epidermis
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    BioTime, Inc. 
    BrainStorm Cell Therapeutics 
    Caladrius Biosciences, Inc. 
    Fibrocell Science, Inc. 
    Opexa Therapeutics, Inc. 
    Pharmicell Co., Inc. 
    Regeneus Ltd. 
    TiGenix NV 
    TxCell SA 
    U.S. Stem Cell, Inc. 
    Vericel Corporation
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Neurology 
    Orthopedics 
    Cancer 
    Wound Healing 
    CVD 
    Autoimmune 
    Others
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now